186
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: Clinical features, treatment outcome and prognostic factors

, , , , , & show all
Pages 734-740 | Received 20 Mar 2010, Accepted 23 Apr 2010, Published online: 04 Jun 2010

References

  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
  • Alberts WM; American College of Chest Physicians. Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:1S–19S.
  • Bow EJ. Infection risk and cancer chemotherapy: the impact of the chemotherapeutic regimen in patients with lymphoma and solid tissue malignancies. J Antimicrob Chemother 1998;41(Suppl D):1–5.
  • Collin BA, Ramphal R. Pneumonia in the compromised host including cancer patients and transplant patients. Infect Dis Clin North Am 1998;12:781–805.
  • Pizzo PA. Fever in immunocompromised patients. N Engl J Med 1999;341:893–900.
  • Capelastegui A, Espana PP, Quintana JM, Areitio I, Gorordo I, Egurrola M, . Validation of a predictive rule for the management of community-acquired pneumonia. Eur Respir J 2006; 27:151–7.
  • Ewig S, de Roux A, Bauer T, Garcia E, Mensa J, Niederman M, . Validation of predictive rules and indices of severity for community acquired pneumonia. Thorax 2004;59:421–7.
  • Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, . A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997;336:243–50.
  • Aliberti S, Brock GN, Peyrani P, Blasi F, Ramirez JA. The pneumonia severity index and the CRB-65 in cancer patients with community-acquired pneumonia. Int J Tuberc Lung Dis 2009;13:1550–6.
  • Lee JO, Kim DY, Lim JH, Seo MD, Yi HG, Kim YJ, . Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients. Lung Cancer 2008;62:381–4.
  • Benoit DD, Depuydt PO, Peleman RA, Offner FC, Vandewoude KH, Vogelaers DP, . Documented and clinically suspected bacterial infection precipitating intensive care unit admission in patients with hematological malignancies: impact on outcome. Intensive Care Med 2005;31:934–42.
  • DeRyke CA, Lodise TP Jr, Rybak MJ, McKinnon PS. Epidemiology, treatment, and outcomes of nosocomial bacteremic Staphylococcus aureus pneumonia. Chest 2005;128:1414–22.
  • Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710–7.
  • Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649–55.
  • Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003;58:377–82.
  • Ewig S, Ruiz M, Mensa J, Marcos MA, Martinez JA, Arancibia F, . Severe community-acquired pneumonia. Assessment of severity criteria. Am J Respir Crit Care Med 1998;158:1102–8.
  • Bohte R, van Furth R, van den Broek PJ. Aetiology of community-acquired pneumonia: a prospective study among adults requiring admission to hospital. Thorax 1995;50: 543–7.
  • Boersma WG, Daniels JM, Lowenberg A, Boeve WJ, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respir Med 2006;100:926–32.
  • Nguyen ET, Kanne JP, Hoang LM, Reynolds S, Dhingra V, Bryce E, . Community-acquired methicillin-resistant Staphylococcus aureus pneumonia: radiographic and computed tomography findings. J Thorac Imaging 2008;23: 13–9.
  • Aliberti S, Myers JA, Peyrani P, Blasi F, Menendez R, Rossi P, . The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia. Eur Respir J 2009; 33:142–7.
  • Jones RN. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia. Clin Infect Dis 1999;29: 495–502.
  • Gordon MS. Managing anemia in the cancer patient: old problems, future solutions. Oncologist 2002;7:331–41.
  • Pirker R, Wiesenberger K, Pohl G, Minar W. Anemia in lung cancer: clinical impact and management. Clin Lung Cancer 2003;5:90–7.
  • Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 2001;91:2214–21.
  • Morere JF. Role of epoetin in the management of anaemia in patients with lung cancer. Lung Cancer 2004;46:149–56.
  • Vento S, Cainelli F, Temesgen Z. Lung infections after cancer chemotherapy. Lancet Oncol 2008;9:982–92.
  • Simmon GR, Turrisi A. Management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007;132:324S–39S.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.